Smart Pills for Psychosis
The Tricky Ethical Challenges of Digital Medicine for Serious Mental Illness
I recently published a commentary on Abilify MyCite, the first smart drug approved for the treatment of schizophrenia and bipolar disorder in the American Journal of Bioethics.
![screenshot of AJOB article](https://annaswartz.com/wp-content/uploads/2018/09/Screen-Shot-2018-09-30-at-12.13.39-AM-1-1024x398.png)